Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Carmot Therapeutics, Inc.

Clinical trials sponsored by Carmot Therapeutics, Inc., explained in plain language.

Now part of Roche Holding AG RHHBY OTC

A biotech developing drugs for metabolic diseases like obesity.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 3

New weekly shot shows promise for weight loss and diabetes

Disease control Ongoing

This study tests a new weekly injection called enicepatide (CT-388) in 447 overweight or obese adults with type 2 diabetes. Participants receive either the drug or a placebo for 48 weeks. The goal is to see if the drug helps with weight loss and improves blood sugar levels.

Phase: PHASE2 • Sponsor: Carmot Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC